1.The value of presepsin, procalcitonin, and C-reactive protein in sepsis associated organ failure in the emergency department: a retrospective analysis according to the Sepsis-3 definition
Eun-Kyeol RHYU ; Young-Hoon YOON ; Jung-Youn KIM ; Young-Duck CHO ; Sung-Jun PARK ; Bo-Sun SHIM
Journal of the Korean Society of Emergency Medicine 2024;35(2):124-133
Objective:
Early diagnosis of sepsis is essential for bundle treatment. The purpose of this study was to determine the clinical significance of presepsin in sepsis related organ failure in the emergency department compared to other inflammatory markers.
Methods:
This was a retrospective review. Enrolled patients were divided into three groups, namely non-infectious organ failure, sepsis, and septic shock groups. The efficacy of presepsin, procalcitonin, and C-reactive protein (CRP) in discriminating sepsis were compared among the three patient groups. The presepsin, procalcitonin, and CRP levels were compared between 28-day survivors and non-survivors among those with sepsis.
Results:
A total of 277 patients with organ failure were included. The areas under the receiver operating characteristic curve (AUROCs) of presepsin, procalcitonin, and CRP for differentiating sepsis from non-infectious organ failure were 0.622, 0.777, and 0.809, respectively. The areas under the curve (AUCs) of presepsin, procalcitonin, and CRP for differentiating sepsis from septic shock were 0.717, 0.667, and 0.609, respectively. The AUCs of presepsin, procalcitonin, and CRP for predicting sepsis related mortality were 0.743, 0.635, and 0.632, respectively. Sepsis patients with high presepsin levels had a higher mortality than those with lower presepsin levels.
Conclusion
Presepsin is a good marker to differentiate septic shock from sepsis and predict mortality. CRP can aid the differential diagnosis of non-infectious causes in patients with organ failure.
2.Frontalis Suspension Surgery for Patients with Essential Blepharospasm Unresponsive to Botulinum Toxin Injections
Sujin YEO ; Kyung In WOO ; Yoon-Duck KIM
Journal of the Korean Ophthalmological Society 2023;64(6):459-465
Purpose:
To report the efficacy of frontalis suspension using a silicone rod or preserved fascia lata for patients with blepharospasm who exhibit persistent symptoms and visual dysfunction unresponsive to botulinum injections.
Methods:
The clinical records of five patients (10 eyes) with essential blepharospasm who underwent frontalis suspension were reviewed. Patients who continued to report eyelid-opening difficulties despite prior administration of botulinum toxin were included.
Results:
The mean patient age was 60.2 years; and 40% of the patients were women. The frontalis was suspended using silicone rods (n = 3) or preserved fascia lata (n = 2). Blepharospasm frequency and severity were measured using the Jankovic Rating Scale (JRS). Compared with preoperative scores, the summed JRS scores decreased 1 week, 1 month, and 3 months after surgery. Postoperatively, two patients (40%) did not require further botulinum toxin injections. In three patients, the intervals between injections were increased after surgery. No patient experienced any significant complication.
Conclusions
Frontalis suspension is safe and effective for patients with blepharospasm and apraxia of eyelid opening, who have not responded to botulinum toxin injections.
3.Allergen sensitization trajectories in children with respiratory and allergic diseases
So Won JO ; Soyoung JEON ; Hye Sun LEE ; Ha Min KIM ; Yoon Young NO ; Mi Reu PARK ; Jae Hwa JUNG ; Soo Yeon KIM ; Jong Duck KIM ; Min Jung KIM ; Yong Ju LEE ; Kyung Won KIM ; Myung Hyun SOHN ; Yoon Hee KIM
Allergy, Asthma & Respiratory Disease 2023;11(1):34-42
Purpose:
There is a lack of a report about the trajectories of allergen sensitization, although it is important to understand the change of allergen sensitization to manage allergic disease. This study aimed to analyze the change and trajectories of allergen sensitization in children with respiratory and allergic diseases.
Methods:
From 2006 to 2020, children with respiratory and allergic diseases or screened for allergic sensitization were evaluated. We visualized the alterations and the trajectories of allergen sensitization using stacked area graphs, box plots, and Sankey diagrams.
Results:
A total of 2,804 subjects were included, and allergic rhino-conjunctivitis was diagnosed in 1,931 children (68.9%). The mean age for the first test was 4.1 years, and that for the second test was 6.5 years. Children sensitized to class 1 food allergen before age 5 showed sensitizations more for other allergens and at a younger age after age 5 than children who were not. The atopic tendency continued once it had been obtained before the early school age in the persistence or the new development of sensitization.
Conclusion
Allergen sensitization has changed over time and has shown different patterns according to age. Its trajectory has taken a wide variety of courses in children with respiratory and allergic diseases until the early school age. These changes reflect the allergic diseases and socio-environmental characteristics of children and adolescents.
4.Circulating Tumor DNA–Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas
Seok Jin KIM ; Yeon Jeong KIM ; Sang Eun YOON ; Kyung Ju RYU ; Bon PARK ; Donghyun PARK ; Duck CHO ; Hyun-Young KIM ; Junhun CHO ; Young Hyeh KO ; Woong-Yang PARK ; Won Seog KIM
Cancer Research and Treatment 2023;55(1):291-303
Purpose:
Plasma circulating tumor DNA (ctDNA) could reflect the genetic alterations present in tumor tissues. However, there is little information about the clinical relevance of cell-free DNA genotyping in peripheral T-cell lymphoma (PTCL).
Materials and Methods:
After targeted sequencing plasma cell-free DNA of patients with various subtypes of PTCL (n=94), we analyzed the mutation profiles of plasma ctDNA samples and their predictive value of dynamic ctDNA monitoring for treatment outcomes.
Results:
Plasma ctDNA mutations were detected in 53 patients (56%, 53/94), and the detection rate of somatic mutations was highest in angioimmunoblastic T-cell lymphoma (24/31, 77%) and PTCL, not otherwise specified (18/29, 62.1%). Somatic mutations were detected in 51 of 66 genes that were sequenced, including the following top 10 ranked genes: RHOA, CREBBP, KMT2D, TP53, IDH2, ALK, MEF2B, SOCS1, CARD11, and KRAS. In the longitudinal assessment of ctDNA mutation, the difference in ctDNA mutation volume after treatment showed a significant correlation with disease relapse or progression. Thus, a ≥ 1.5-log decrease in genome equivalent (GE) between baseline and the end of treatment showed a significant association with better survival outcomes than a < 1.5-log decrease in GE.
Conclusion
Our results suggest the clinical relevance of plasma ctDNA analysis in patients with PTCL. However, our findings should be validated by a subsequent study with a larger study population and using a broader gene panel.
5.Self-Symptom Checker for COVID-19 Control and Symptom Management
Sun-Ju AHN ; Jong Duck KIM ; Jong Hyun YOON ; Jung Ha PARK
Health Policy and Management 2023;33(1):29-39
Background:
Breaking the chain of disease transmission from overseas is necessary to control new infectious diseases such as coronavirus disease 2019 effectively. In this study, we developed a mobile app called Self-Symptom Checker (SSC) to monitor the health of inbound travelers.
Methods:
SSC was developed for general users and administrators. The functions of SSC include non-repudiation using QR (quick response) codes, monitoring fever and respiratory symptoms, and requiring persons showing symptoms to undergo polymerase chain reaction tests at nearby screening stations following a review of reported symptoms by the Korea Disease Control and Prevention Agency, as well as making phone calls, via artificial intelligence or public health personnel, to individuals who have not entered symptoms to provide the necessary information.
Results:
From February 12 to March 27, 2020, 165,000 people who were subjected to the special entry procedure installed SSC. The expected number of public health officers and related resources needed per day would be 800 if only the phone was used to perform symptom monitoring during the above period.
Conclusion
By applying SSC, more effective symptom monitoring was possible. The daily average number of health officers decreased to 100, or 13% of the initial estimate. SSC reduces the work burden on public healthcare personnel. SSC is an electronic solution conceived in response to health questionnaires completed by inbound travelers specified in the World Health Organization International Health Regulations as a requirement in the event of a pandemic.
6.An analysis of HIV patients visiting hospitals in Korea by complete enumeration:based on the Health Insurance Review and Assessment Service database
Ye-Chun NOH ; Jung-Youn KIM ; Young-Duck CHO ; Geum-Joon CHO ; Sung-Jun PARK ; Young-Hoon YOON ; Eun-Seog HONG
Journal of the Korean Society of Emergency Medicine 2022;33(3):252-261
Objective:
This study investigated the hospital use patterns of patients with human immunodeficiency virus (HIV) infections in Korea. The prevalence of HIV infections in Korea is very low and there is no data on the type of medical treatment HIV patients receive. We therefore decided to perform a complete enumeration of the utilization of medical facilities by HIV patients using a nationwide claims database.
Methods:
The nationwide Health Medical Insurance Review and Assessment (HIRA) service claims database was used to identify and include all new patients with HIV infections from 2013 to 2018. The current inpatient, outpatient, and emergency service use of these patients were investigated. The number of invasive procedures, interventions, and operations performed on these patients, and their death rate, was also investigated.
Results:
The number of patients visiting outpatient departments increased by 44% from 2013 to 2018. The most frequently visited department was internal medicine, followed by emergency medicine. Dental procedures followed intravenous line insertions as the most common procedures undertaken by patients with HIV.
Conclusion
The results of this study show the status of hospital visits by patients with HIV infections in Korea and provide the basic data upon which policy decisions can be based.
7.The effect of COVID-19 epidemic on 119 transportation time for severely ill patients
Jong Eun PARK ; Sung-Hyuk CHOI ; Young-Hoon YOON ; Jung-Yoon KIM ; Young-Duck CHO ; Ji Young LEE ; Sung Joon PARK
Journal of the Korean Society of Emergency Medicine 2022;33(5):497-505
Objective:
As the coronavirus disease 2019 (COVID-19) pandemic continues, it is believed that COVID-19 may have affected the transportation time of 119 emergency medical services (EMS). However, there are only a few studies to support this claim. The current study was undertaken to investigate the altered pre-hospital transportation time according to the severity of the patient after the COVID-19 period.
Methods:
This is a retrospective observational study conducted on patients aged 15 or older who visited three emergency medical centers from January 1, 2019, to December 31, 2020, using the 119 EMS. The primary outcome was total pre-hospital transportation time; secondary outcomes include activation time, response time, on-scene, and transportation time.
Results:
Before COVID-19, the total pre-hospital transportation times for patients admitted to the intensive care unit and patients with out-of-cardiac arrest were 26.78±9.91 minutes and 27.92±8.38 minutes, respectively. Post-COVID-19, the time increased to 35.31±16.30 minutes and 32.46±14.69 minutes, respectively (P<0.001). Furthermore, the total pre-hospital transportation time before and after COVID-19 differed in the critical patient group with Korean Triage and Acuity Scale 1 and 2 (26.58±10.12 minutes vs. 33.93±15.78 minutes). In addition, an increase in the total pre-hospital transportation time was observed after COVID-19 in the emergency and non-emergency patient groups. An increased time interval was also determined for the activation time, response time, on-scene arrival, and transportation time for all patient groups after the COVID-19 pandemic (P<0.001).
Conclusion
COVID-19 has resulted in delays throughout the pre-hospital transportation time, greatly impacting critical patients.
8.Plasma Circulating Tumor DNA in Patients with Primary Central Nervous System Lymphoma
Sang Eun YOON ; Yeon Jeong KIM ; Joon Ho SHIM ; Donghyun PARK ; Junhun CHO ; Young Hyeh KO ; Woong-Yang PARK ; Yeung-Chul MUN ; Kyoung Eun LEE ; Duck CHO ; Won Seog KIM ; Seok Jin KIM
Cancer Research and Treatment 2022;54(2):597-612
Purpose:
Analysis of circulating tumor DNA (ctDNA) in blood could allow noninvasive genetic analysis of primary tumors. Although there have been unmet needs for noninvasive methods in patients with primary central nervous system lymphoma (PCNSL), it is still not determined whether plasma ctDNA analysis could be useful for patients with PCNSL.
Materials and Methods:
Targeted deep sequencing of 54 genes was performed in cell-free DNA isolated from plasma samples collected pretreatment, during treatment, and at the end of treatment in 42 consecutively diagnosed PCNSL patients between January 2017 and December 2018.
Results:
Targeted sequencing of plasma cell-free DNA detected somatic mutations representing ctDNA in 11 cases (11/41, 27%). The detection of ctDNA was not related to the concentration of cell-free DNA or tumor volume. The mutation profiles of these 11 cases varied between patients. The most frequently mutated gene was PIM1 (4/11, 36.4%), whereas KMT2D, PIK3CA, and MYD88 were each observed in three patients (3/11, 27%). The mutations of 13 genes were concordantly found in primary tumor tissue and plasma ctDNA, giving a detection sensitivity of 45%. During the serial tracking of seven patients with complete response, the disappearance of ctDNA mutations was found in four patients, whereas three patients had detected ctDNA mutation at the end of treatment.
Conclusion
The plasma ctDNA mutation analysis still has limited value for surveillance and predicting treatment outcomes of PCNSL because the detection efficiency was lower than other systemic lymphomas. Thus, analytical platforms should be improved to overcome anatomical hurdles associated with PCNSL.
9.Red Blood Cell Autoantibodies in Patients Treated with Immune Checkpoint Inhibitors
Eungjun YOON ; Tae Yeul KIM ; Sun Kyoung MUN ; Duck CHO
Korean Journal of Blood Transfusion 2021;32(3):201-208
Immune-related adverse events, including immune hemolytic anemia, have been reported in patients treated with immune checkpoint inhibitors. In particular, RBC autoantibodies are important because they can cause hemolytic anemia and interfere with pre-transfusion tests. On the other hand, there are few reports on the characteristics of RBC autoantibodies induced by immune checkpoint inhibitors in Korea. The medical history and laboratory results, including pretransfusion tests of ten patients treated with immune checkpoint inhibitors, were reviewed retrospectively. The median interval from the first administration of immune checkpoint inhibitors to the development of autoantibodies was 12 weeks. In eight patients, only cold autoantibodies were developed. Both warm and cold autoantibodies developed in one patient, and warm autoantibodies alone were detected in one patient.Of seven patients tested by a direct antiglobulin test, two were negative, and the remaining five were positive for IgG and negative for C3d. In conclusion, this study presented ten cases of autoantibody developments in patients treated with immune checkpoint inhibitors and the possible relationship between the immune checkpoint inhibitors and RBC autoantibody development. Further comprehensive studies will be needed to elucidate this relationship.
10.Novel Ablation Therapy Using Endoscopic Irreversible Electroporation in the Bile Duct: A Pilot Animal Study
Kang Won LEE ; Jae Min LEE ; Hyuk Soon CHOI ; Eun Sun KIM ; Bora KEUM ; Yeon Seok SEO ; Yoon Tae JEEN ; Soon Ho UM ; Hong Sik LEE ; Hoon Jai CHUN ; Chang Duck KIM ; Chi Hyuk OH ; Hong Bae KIM
Clinical Endoscopy 2021;54(3):413-419
Background/Aims:
Irreversible electroporation (IRE) is a relatively new ablation method. However, the application of IRE ablation in the treatment of biliary disease has not been attempted. A minimally invasive approach using endoscopic retrograde cholangiopancreatography (ERCP) can be a novel therapeutic modality for IRE ablation. In this study, we aimed to investigate the feasibility of endoscopic IRE for the biliary tract using an animal model.
Methods:
A new catheter-type electrode was developed for endoscopic IRE ablation of the biliary tract. We performed ERCP and endoscopic IRE ablations in the normal common bile duct of Yorkshire pigs. The experimental setting of IRE was 500 V/cm (50 pulses, 100-µs length). The animals were sacrificed after 24 hr, and the ablated bile duct was examined.
Results:
Well-demarcated focal color changes were observed on the mucosa of the common bile duct. The depth of change after IRE was confined to the mucosal and submucosal layers. Apoptotic changes in the bile duct were observed only around the IRE ablation area. Immunohistochemistry assay showed cell death in the bile duct along the electrode.
Conclusions
Endoscopic IRE ablation using ERCP was successfully performed in the common bile duct. It can be a potential option for the treatment of biliary tumors.

Result Analysis
Print
Save
E-mail